NCT00436527View on ClinicalTrials.gov

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

PHASE4CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Rosacea

Interventions

DRUG

Metronidazole gel 1%

Applied once to a test site on the right or left cheek (as determined by a randomization design)

Trial Locations (1)

80915

Colorado Springs Research Center, Colorado Springs

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY